Cancer Immunotherapy

Activation of the COX2-PGE₂ axis by immune effector cells results in the self-limiting nature of type-1 immunity in cancer tissues
Jeffrey L Wong, Natasa Obermajer, Ravikumar Muthuswamy, Robert P Edwards, Kunle Odunsi, David L Bartlett, Pawel Kalinski

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P239; DOI: 10.1186/2051-1426-2-S3-P239
Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
Anna R Kwilas, Andressa Ardiani, Renee N Donahue, Dana Aftab, James W Hodge

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P185; DOI: 10.1186/2051-1426-2-S3-P185
Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
Gitte Holmen Olofsson, Manja Idorn, Wajid Khan, Mads Hald Andersen, Bernhard Moser, Per thor Straten

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P18; DOI: 10.1186/2051-1426-2-S3-P18
Engineering the immune response to "self" for effective cancer immunotherapy
Shi Zhong, Karolina Malecek, Duane Moogk, Laura A Johnson, Zhiya Yu, Arsen Grigoryan, Eleazar Vega-Saenz de Miera, Farbod Darvishian, Wei Jun Gu, Katelyn McGary, Kevin Huang, Joshua Boyer, Emily Corse, Shao Yongzhao, Steven A Rosenberg, Nicholas P Restifo, Timothy Cardozo, Alan Frey, Iman Osman, Michelle Krogsgaard

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P22; DOI: 10.1186/2051-1426-2-S3-P22
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen, Peter Mohr

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 27; DOI: 10.1186/s40425-014-0027-z
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
G Cojocaru, G Rotman, O Levy, A Toporik, L Dassa, I Vaknin, S Sameah-Greenwald, I Barbiro, E Neria, Z Levine

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) I5; DOI: 10.1186/2051-1426-2-S2-I5
P58. Can T-cells predict response to intravesical BCG immunotherapy in high-risk non-invasive bladder cancer
S Jallad, P Thomas, M Newport, F Kern

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P32; DOI: 10.1186/2051-1426-2-S2-P32
Identification of novel immune checkpoints as targets for cancer immunotherapy
Galit Rotman, Ofer Levy, Amir Toporik, Gady Cojocaru, Liat Dassa, Iris Hecht, Ilan Vaknin, Anat Oren, Zohar Tiran, Nora Tarcic, Sergey Nemzer, Tania Pergam, Amit Novik, Shirley Sameah-Greenwald, Joseph R Podojil, Stephen D Miller, Judith Leitner, Peter Steinberger, Eyal Neria, Zurit Levine

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P135; DOI: 10.1186/2051-1426-1-S1-P135
Expression of cancer testis antigens and its correlation with clinicopathological parameters in hepatocellular carcinoma
Meng Wang, Xin-feng Chen, Zhi-qin Li, Zhen Zhang, Dong-li Yue, Yan-hong Liu, Dong Jiang, Yu-ling Sun, Yong-fu Zhao, Shu-huan Wu, Jian-sheng Li, Yi Zhang

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P250; DOI: 10.1186/2051-1426-1-S1-P250
Immunosuppression through HNF-1β signaling in human ovarian clear cell cancer
Hiroshi Nishio, Juri Sugiyama, Tomonori Yaguchi, Daisuke Aoki, Yutaka Kawakami

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P168; DOI: 10.1186/2051-1426-1-S1-P168

Main menu

Cancer Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cancer Immunotherapy

Pages